The 2020 30 under 30 Consumer Technology

Fetch Rewards Cofounders, Fetch Rewards Wes Schroll wondered why grocery loyalty programs rewarded people for being loyal to a store and not the brands they were buying. Today, over two million people use Fetch's app to scan their receipts and receive points from...

read more

Pops on the go virtual care system empowers those with diabetes to Own Their Life®

Over 400 million individuals worldwide, according to the World Health Organization (WHO), have diabetes, living each day on the precipice of health determined by the level of sugar in their bloodstream.  The vigilance required to ensure that their levels are neither too high nor too low can often become all-encompassing. A circumstance that Lonny Stormo, co-founder and CEO of the Oak Park Heights, Minnesota-based startup, Pops, truly understands.

read more

New ways to make molybdenum-99

A crucial short-lived isotope is in short supply

One fear raised by those who oppose Britain’s leaving the European Union without a deal is that the import of radioactive isotopes for medicine would be at risk. These short-lived substances might, people wo

read more

Curate Solutions named ‘most innovative’ in Madison

Curate Wins Chamber Innovation Award November 14, 2019 - General & Events - Tagged: Curate, Greater Madison Chamber of Commerce - no comments by Brian Lee Curate won the Greater Madison Chamber of Commerce’s fourth annual Most Innovative Company award Wednesday at...

read more

myTAIHEART Test Provides Evidence for Injury from Biopsy of Heart Transplant Recipients

MILWAUKEE, Wis.–(BUSINESS WIRE)–TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication, “Effect of endomyocardial biopsy on levels of donor-specific cell-free DNA” in the October, 2019 issue of The Journal of Heart and Lung Transplantation. The clinical study presented in the paper was conducted jointly by Steven Zangwill, MD, Karl Stamm, PhD, Mats Hidestrand, PhD, Aoy Tomita-Mitchell, PhD and Michael Mitchell, MD.

read more

Invenra Announces Expansion of Collaboration with Exelixis

MADISON, WI, USA, Oct 31, 2019 – Invenra Inc. announced that it has expanded its collaboration with Exelixis, Inc. (Nasdaq: EXEL). Exelixis and Invenra had entered into a collaboration on May 2nd, 2018 to discover and develop multispecific antibodies through the use...

read more

Curate is now live in all 50 states

I’m thrilled to announce that Curate has expanded to cover all 50 U.S. states. Expanding our geographic footprint has been a huge push over the last few months, and our hard work has now paved the way for us to welcome hundreds of new customers across the country. In...

read more

Shine Medical Technologies debuts therapeutics division

Medical isotopes maker Shine Medical Technologies last week created a division to make therapeutic products, saying it plans to first focus on a cancer treatment. The Janesville, Wis.-based company said its Shine Therapeutics business will begin with the development...

read more